Shattuck Labs, Inc. Common Stock (STTK) is a publicly traded Healthcare sector company. As of July 5, 2026, STTK trades at $7.05 with a market cap of $673.33M and a P/E ratio of -11.95. STTK moved +8.45% today. Year to date, STTK is +95.83%; over the trailing twelve months it is +732.35%. Its 52-week range spans $0.69 to $8.33. Analyst consensus is strong buy with an average price target of $15.80. Rallies surfaces STTK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
7 analysts cover STTK: 0 strong buy, 7 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $15.80.
| Metric | Value |
|---|---|
| Price | $7.05 |
| Market Cap | $673.33M |
| P/E Ratio | -11.95 |
| EPS | $-0.59 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.33 |
| 52-Week Low | $0.69 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.00M |
| Net Income | $-49.87M |
| Gross Margin | 0.00% |
7 analysts cover STTK: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $15.80.